| Name | Title | Contact Details |
|---|
Instantly Create & Publish Augmented Reality Experiences on the Web. Drag & Drop Templates. No App Downloads Required. Easy Sharing on Social.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
ITSM by ITarian is a complete IT Service Management and Security Platform that provides RMM, Remote Access, Service Desk to MSPs and Enterprises.
Sonar Software gives you a clear view into your tech stack, so you can simplify complex change and never break a critical process again.
Ritual is a social ordering app that taps networks of co-workers and colleagues for fast and easy pick up and pay at a wide variety of local restaurants and coffee shops.